|
NCT02071901
|
2014-08-01 |
Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
|
Phase 2
|
Recruiting
|
|
NCT01772420
|
2012-10-01 |
Lenalidomide and Eltrombopag Olamine in Treating Patients With Symptomatic Anemia in Low or Intermediate Myelodysplastic Syndrome
|
Phase 2
|
Recruiting
|
|
NCT01610180
|
2012-06-01 |
Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)
|
Phase 2
|
Recruiting
|
|
NCT01550185
|
2012-05-01 |
Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia
|
Phase 1
|
Recruiting
|
|
NCT01830660
|
2012-04-01 |
A Phase I Study of Hetrombopag Olamine in Healthy Adult Volunteers
|
Phase 1
|
Recruiting
|
|
NCT01139749
|
2011-10-01 |
Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea
|
Phase 4
|
Recruiting
|
|
NCT01147809
|
2010-06-01 |
Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
|
Phase 2
|
Active, Not Recruiting
|
|
NCT01098487
|
2010-05-01 |
A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
|
Phase 4
|
Completed
|
|
NCT00990587
|
2009-10-01 |
Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy
|
Phase 1
|
Active, Not Recruiting
|
|
NCT00903422
|
2009-05-01 |
Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS)
|
Phase 1
|
Completed
|
|
NCT01173965
|
2008-01-01 |
Endometrial Ablation With Non-hysteroscopic Methods
|
Phase 4
|
Completed
|
|
NCT00351468
|
2006-06-01 |
EXTEND (Eltrombopag Extended Dosing Study)
|
Phase 3
|
Active, Not Recruiting
|
|
NCT00802672
|
2003-12-01 |
Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea Pedis
|
Phase 3
|
Completed
|